Ganjiaxin tablet

A kind of technology of Xin tablet and weight, which is applied in the direction of plant raw materials, pill delivery, digestive system, etc., can solve the problems of low therapeutic effect and uneven effect, and achieve the effect of definite curative effect, proper compatibility and reasonable composition

Inactive Publication Date: 2009-03-18
SHANGHAI FANGDA PHARMA
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] In the prior art, there are many kinds of medicines for treating liver diseases, with different effects, and their prescriptions have their own merits, but the disadvantage is that the therapeutic effect is low

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Example 1: Ganjiaxin Tablets

[0016] Ganjiaxin tablets consist of 317.5g schisandra chinensis, 300g Bupleurum chinensis, 300g capillary root, 300g banlangen, 20g intracellular glycopeptide of versicolor versicolor, 20g pig gall powder, 100g starch, and 3.5g magnesium stearate, making 1000 tablets.

experiment example 1

[0017] Experimental Example 1: Clinical Report

[0018] Summary

[0019] Liver depression and spleen deficiency syndrome is the most common syndrome of spleen-stomach disease. The reason is that the liver and spleen are out of balance, and the liver fails to ventilate, which in turn affects the spleen's transportation and chemical function or causes the spleen to be weak, and the biochemistry of qi and blood has no source, resulting in liver blood Not enough to nourish the liver. The liver loses its place to support, and the Qi stagnation stagnates. Clinically, there are often syndromes of stagnation of liver qi and weakness of spleen qi. In this experiment, according to the standard of TCM dialectics, the clinical research and evaluation of Ganjiaxin Tablets was carried out on patients with stagnation of liver qi and weakness of spleen qi according to the treatment plan. At the same time, combined with the observation of changes in its liver function and hepatitis B virus ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a Chinese materia medica preparation, i.e. a ganjiaxin tablet for treating hepatic diseases. 1000 ganjiaxin tablets are made from 317.5g of Chinese magnolivine fruit, 300g of bupleurum root, 300g of oriental wormwood, 300g of isatis root, 20g of polystictus glycopeptide, 20g of pig gall powder, 100g of starch and 3.5g of magnesium stearate. The tablet is used for treating diseases such as chronic viral hepatitis, persistent hepatitis, hepatocirrhosis and the like, and has the advantage of reliable and significant curative effect.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, namely Ganjiaxin Tablets, which are used for treating liver diseases. Background technique [0002] In the prior art, there are many kinds of medicines for treating liver diseases with different effects, and the prescriptions have their own merits, but the disadvantage is that the therapeutic effect is low. Contents of the invention [0003] The object of the present invention is to provide a Ganjiaxin tablet with better curative effect for treating liver diseases in view of the above deficiencies. [0004] The technical solution of the present invention is: a Ganjiaxin tablet, which is characterized in that it is made of the following raw materials: 317.5g of schisandra, 300g of Bupleurum, 300g of capillary, 300g of Radix Radix, 20g of intracellular glycopeptide of Yunzhi, pig 20g of gall powder, 100g of starch, 3.5g of magnesium stearate, made into 1000 tablets. [0005] Fangzho...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/57A61K38/02A61K9/20A61P1/16A61K35/413
Inventor 鞠然
Owner SHANGHAI FANGDA PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap